The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
Open accessAbstract
BACKGROUND: Riociguat, a member of a new class of compounds (soluble guanylate cyclase stimulators), has been shown in previous clinical studies to be beneficial in the treatment of chronic thromboembolic pulmonary hypertension. METHODS: In this phase 3, multicenter, randomized, double-blind, placebo-controlled study, we randomly assigned 261 patients with inoperable chronic thromboembolic pulmonary hypertension or persistent or recurrent pulmonary hypertension after pulmonary endarterectomy to receive placebo or riociguat. The primary end point was the change from baseline to the end of week 16 in the distance walked in 6 minutes. Secondary end points included changes from baseline in pulmonary vascular resistance, N-terminal pro-brain natriuretic peptide (NT-proBNP) level, World Health Organization (WHO) functional class, time to clinical worsening, Borg dyspnea score, quality-of-life variables, and safety. RESULTS: By week 16, the 6-minute walk distance had increased by a mean of 39 m in the riociguat group, as compared with a mean decrease of 6 m in the placebo group (least-squares mean difference, 46 m; 95% confidence interval [CI], 25 to 67; P<0.001). Pulmonary vascular resistance decreased by 226 dyn·sec·cm(-5) in the riociguat group and increased by 23 dyn·sec·cm(-5) in the placebo group (least-squares mean difference, -246 dyn·sec·cm(-5); 95% CI, -303 to -190; P<0.001). Riociguat was also associated with significant improvements in the NT-proBNP level (P<0.001) and WHO functional class (P=0.003). The most common serious adverse events were right ventricular failure (in 3% of patients in each group) and syncope (in 2% of the riociguat group and in 3% of the placebo group). CONCLUSIONS: Riociguat significantly improved exercise capacity and pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension. (Funded by Bayer HealthCare; CHEST-1 and CHEST-2 ClinicalTrials.gov numbers, NCT00855465 and NCT00910429, respectively.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Updated clinical classification of pulmonary hypertension
Simonneau, G., Gatzoulis, M. A., Adatia, I., Celermajer, D., Denton, C., Ghofrani, A., Gomez Sanchez, M. A., Krishna Kumar, R., Landzberg, M., Machado, R. F., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.029 · Cited by 4,191
Self-citationAuthors/Task Force Members, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp297 · Cited by 3,846
Self-citationUpdated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Self-citationLong-term intravenous epoprostenol infusion in primary pulmonary hypertension
Sitbon, O., Humbert, M., Nunes, H., Parent, F., Garcia, G., Hervé, P., Rainisio, M., & Simonneau, G. É. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02012-0 · Cited by 1,383
Self-citationGiaid, A., & Saleh, D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330403 · Cited by 1,369
Guidelines for the diagnosis and treatment of pulmonary hypertension
(2009) · European Respiratory Journal · doi:10.1183/09031936.00139009 · Cited by 1,300
Chronic Thromboembolic Pulmonary Hypertension
Hoeper, M. M., Mayer, E., Simonneau, G., & Rubin, L. J. (2006) · Circulation · doi:10.1161/circulationaha.105.602565 · Cited by 1,148
Self-citationPepke-Zaba, J., Delcroix, M., Lang, I., Mayer, E., Jansa, P., Ambroz, D., Treacy, C., D'Armini, A. M., Morsolini, M., Snijder, R., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.015008 · Cited by 1,059
Self-citationChronic thromboembolic pulmonary hypertension
Kim, N. H., Delcroix, M., Jais, X., Madani, M. M., Matsubara, H., Mayer, E., Ogo, T., Tapson, V. F., Ghofrani, H.-A., & Jenkins, D. P. (2019) · European Respiratory Journal · doi:10.1183/13993003.01915-2018 · Cited by 1,007
Self-citationLongterm Follow-up of Patients with Pulmonary Thromboembolism
Riedel, M., Stanek, V., Widimsky, J., & Prerovsky, I. (1982) · Chest · doi:10.1378/chest.81.2.151 · Cited by 830
Pulmonary endarterectomy: experience and lessons learned in 1,500 cases
Jamieson, S. W., Kapelanski, D. P., Sakakibara, N., Manecke, G. R., Thistlethwaite, P. A., Kerr, K. M., Channick, R. N., Fedullo, P. F., & Auger, W. R. (2003) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(03)00828-2 · Cited by 770
Mayer, E., Jenkins, D., Lindner, J., D’Armini, A., Kloek, J., Meyns, B., Ilkjaer, L. B., Klepetko, W., Delcroix, M., Lang, I., et al. (2011) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2010.11.024 · Cited by 733
Self-citationSoluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
Stasch, J.-P., Pacher, P., & Evgenov, O. V. (2011) · Circulation · doi:10.1161/circulationaha.110.981738 · Cited by 601
Bosentan for Treatment of Inoperable Chronic Thromboembolic Pulmonary Hypertension
Jaïs, X., D'Armini, A. M., Jansa, P., Torbicki, A., Delcroix, M., Ghofrani, H. A., Hoeper, M. M., Lang, I. M., Mayer, E., Pepke-Zaba, J., et al. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.08.059 · Cited by 550
Self-citationChronic thromboembolic pulmonary hypertension
Dartevelle, P., Fadel, E., Mussot, S., Chapelier, A., Hervé, P., de Perrot, M., Cerrina, J., Ladurie, F. L., Lehouerou, D., Humbert, M., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00079704 · Cited by 447
Self-citationImproved Outcomes in Medically and Surgically Treated Chronic Thromboembolic Pulmonary Hypertension
Condliffe, R., Kiely, D. G., Gibbs, J. S. R., Corris, P. A., Peacock, A. J., Jenkins, D. P., Hodgkins, D., Goldsmith, K., Hughes, R. J., Sheares, K., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200712-1841oc · Cited by 400
Authors/Task Force Members:, Galie, N., Hoeper, M. M., Humbert, M., Torbicki, A., Vachiery, J.-L., Barbera, J. A., Beghetti, M., Corris, P., Gaine, S., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr046 · Cited by 314
Self-citationLong-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension
Provencher, S., Sitbon, O., Humbert, M., Cabrol, S., Jaïs, X., & Simonneau, G. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi728 · Cited by 296
Self-citationPredictors of Outcome in Chronic Thromboembolic Pulmonary Hypertension
Bonderman, D., Skoro-Sajer, N., Jakowitsch, J., Adlbrecht, C., Dunkler, D., Taghavi, S., Klepetko, W., Kneussl, M., & Lang, I. M. (2007) · Circulation · doi:10.1161/circulationaha.106.661041 · Cited by 286
Long-term Use of Sildenafil in Inoperable Chronic Thromboembolic Pulmonary Hypertension
Suntharalingam, J., Treacy, C. M., Doughty, N. J., Goldsmith, K., Soon, E., Toshner, M. R., Sheares, K. K., Hughes, R., Morrell, N. W., & Pepke-Zaba, J. (2008) · Chest · doi:10.1378/chest.07-2681 · Cited by 269
Grimminger, F., Weimann, G., Frey, R., Voswinckel, R., Thamm, M., Bölkow, D., Weissmann, N., Mück, W., Unger, S., Wensing, G., et al. (2009) · European Respiratory Journal · doi:10.1183/09031936.00039808 · Cited by 249
Self-citationGhofrani, H. A., Hoeper, M. M., Halank, M., Meyer, F. J., Staehler, G., Behr, J., Ewert, R., Weimann, G., & Grimminger, F. (2010) · European Respiratory Journal · doi:10.1183/09031936.00182909 · Cited by 240
Self-citationWilkens, H., Konstantinides, S., Lang, I. M., Bunck, A. C., Gerges, M., Gerhardt, F., Grgic, A., Grohé, C., Guth, S., Held, M., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.08.079 · Cited by 219
Self-citationPrognostic and aetiological factors in chronic thromboembolic pulmonary hypertension
Condliffe, R., Kiely, D. G., Gibbs, J. S. R., Corris, P. A., Peacock, A. J., Jenkins, D. P., Goldsmith, K., Coghlan, J. G., & Pepke-Zaba, J. (2009) · European Respiratory Journal · doi:10.1183/09031936.00092008 · Cited by 185
State-of-the-art chronic thromboembolic pulmonary hypertension diagnosis and management
Jenkins, D. P., Mayer, E., Screaton, N., & Madani, M. M. (2012) · European Respiratory Review · doi:10.1183/09059180.00009211 · Cited by 139
Self-citationOutcomes of pulmonary endarterectomy for treatment of extreme thromboembolic pulmonary hypertension
Thistlethwaite, P. A., Kemp, A., Du, L., Madani, M. M., & Jamieson, S. W. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.07.033 · Cited by 131
Lang, M., Kojonazarov, B. K., Xia, T., Kalymbetov, A., Weißmann, N., Grimminger, F., Kretschmer, A., Stasch, J., Seeger, W., Ghofrani, H. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043433 · Cited by 115
Self-citationRiociguat for the treatment of pulmonary hypertension
SCHERMULY, R. T., Janssen, W., Weißmann, N., Stasch, J., Grimminger, F., & Ghofrani, H. A. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.565048 · Cited by 108
Self-citationChronic thromboembolic pulmonary hypertension (CTEPH)
McNeil, K., & Dunning, J. J. (2007) · Heart · doi:10.1136/hrt.2004.053603 · Cited by 104
Peacock, A., Simonneau, G., & Rubin, L. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200605-114lr · Cited by 101
Self-citationWilkens, H., Lang, I. M., Behr, J., Berghaus, T. M., Grohé, C., Guth, S., Hoeper, M. M., Kramm, T., Krüger, U., Langer, F., et al. (2011) · International Journal of Cardiology · doi:10.1016/s0167-5273(11)70493-4 · Cited by 100
Self-citationChronic thromboembolic pulmonary hypertension: an updated review
Lang, I. M., & Klepetko, W. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328311f254 · Cited by 83
Schölzel, B. E., Post, M. C., Plokker, H. W. T., & Snijder, R. J. (2011) · Lung · doi:10.1007/s00408-011-9350-z · Cited by 27
Clinical worsening after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension
Schölzel, B. E., Snijder, R. J., Morshuis, W. J., Saouti, N., Plokker, T. H. W., & Post, M. C. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0203-4 · Cited by 18
Cited by
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationKonstantinides, S. V., Meyer, G., Becattini, C., Bueno, H., Geersing, G.-J., Harjola, V.-P., Huisman, M. V., Humbert, M., Jennings, C. S., Jiménez, D., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz405 · Cited by 4,916
Antithrombotic Therapy for VTE Disease
Kearon, C., Akl, E. A., Ornelas, J., Blaivas, A., Jimenez, D., Bounameaux, H., Huisman, M., King, C. S., Morris, T. A., Sood, N., et al. (2016) · Chest · doi:10.1016/j.chest.2015.11.026 · Cited by 4,830
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Humbert, M., Kovacs, G., Hoeper, M. M., Badagliacca, R., Berger, R. M. F., Brida, M., Carlsen, J., Coats, A. J. S., Escribano-Subias, P., Ferrari, P., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac237 · Cited by 3,975
Self-citationGaliè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citation
Metadata
- Authors
- Ghofrani, H.-A., D'Armini, A. M., Grimminger, F., Hoeper, M. M., Jansa, P., Kim, N. H., Mayer, E., Simonneau, G., Wilkins, M. R., Fritsch, A., Neuser, D., Weimann, G., & Wang, C.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-07-25
- Volume
- 369
- Issue
- 4
- Pages
- 319-329
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2116338856
- Cited by
- 1,401
- References
- 34
- FWCI
- 95.00
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.